clofarabine has been researched along with Neutropenia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bixby, DL; Crouch, A; Marini, BL; Nachar, VR; Perissinotti, AJ; Scappaticci, GB; Talpaz, M; Uebel, JR; Vulaj, V | 1 |
| Aleem, A; Algahtani, F; Almomen, A; Alsaleh, K; Anjum, F; Iqbal, Z | 1 |
| Feldman, E; Ippoliti, C; James, S; Roboz, GJ; Savva, D; Thomas, CM; van Besien, K | 1 |
| Baiocchi, R; Blum, KA; Byrd, JC; Devine, SM; Hamadani, M; Johnson, AJ; Lin, TS; Lozanski, G; Lucas, DM; Phillips, GS; Porcu, P; Smith, LL | 1 |
| Albano, E; Altman, A; Arceci, R; Bomgaars, L; Gaynon, P; Goldman, S; Jeha, S; Kadota, R; Luchtman-Jones, L; Razzouk, B; Rheingold, S; Ritchey, K; Rytting, M; Steinherz, L; Steinherz, P; Stine, K | 1 |
| Arellano, M; Claxton, D; Erba, HP; Faderl, S; Gabrilove, J; Gandhi, PJ; Huebner, D; Kantarjian, H; Kovacsovics, T; Lyons, RM | 1 |
| Amin, C; Barr, ND; Chiu, WM; Foster, MC; Ivanova, A; Richards, KL; Shea, T; van Deventer, HW; Voorhees, PM; Whitman, J | 1 |
| DiPersio, JF; Ruddell, A; Tomasson, MH; Uy, GL; Vij, R | 1 |
4 trial(s) available for clofarabine and Neutropenia
| Article | Year |
|---|---|
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.
Topics: Adenine Nucleotides; Aged; Arabinonucleosides; Clofarabine; Female; Hematopoiesis; Humans; Kinetics; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myeloablative Agonists; Neutropenia; Remission Induction; Salvage Therapy; Survival Analysis; Thrombocytopenia | 2009 |
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.
Topics: Acute Disease; Adenine Nucleotides; Adolescent; Antineoplastic Agents; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Drug Resistance, Neoplasm; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Nausea; Neutropenia; Recurrence; Remission Induction; Treatment Outcome; Young Adult | 2009 |
Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia.
Topics: Acute Kidney Injury; Adenine Nucleotides; Aged; Ambulatory Care; Antimetabolites, Antineoplastic; Arabinonucleosides; Clofarabine; Consolidation Chemotherapy; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Hypokalemia; Inpatients; Length of Stay; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Outpatients; Pneumonia; Quality of Life | 2012 |
A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemia.
Topics: Acute Disease; Adenine Nucleotides; Adult; Alanine Transaminase; Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Aspartate Aminotransferases; Clofarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gemtuzumab; Humans; Infusions, Intravenous; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Recurrence; Survival Analysis; Treatment Outcome; Young Adult | 2012 |
4 other study(ies) available for clofarabine and Neutropenia
| Article | Year |
|---|---|
Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAG.
Topics: Adenine Nucleotides; Aged; Aged, 80 and over; Aging; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Case-Control Studies; Chemical and Drug Induced Liver Injury; Clofarabine; Cohort Studies; Combined Modality Therapy; Cost Savings; Costs and Cost Analysis; Cytarabine; Granulocyte Colony-Stimulating Factor; Hospital Costs; Humans; Incidence; Induction Chemotherapy; Length of Stay; Leukemia, Myeloid, Acute; Michigan; Middle Aged; Neutropenia; Propensity Score; Retrospective Studies; Survival Analysis; Tertiary Care Centers; Vidarabine | 2018 |
Clofarabine in the treatment of elderly patients with acute myeloid leukemia.
Topics: Adenine Nucleotides; Aged; Aged, 80 and over; Aging; Antimetabolites, Antineoplastic; Arabinonucleosides; Clofarabine; Disease-Free Survival; Female; Hand-Foot Syndrome; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Remission Induction; Retrospective Studies; Survival; Treatment Outcome | 2013 |
Clofarabine as a bridge to hematopoietic stem cell transplant.
Topics: Acute Disease; Adenine Nucleotides; Adult; Aged; Antimetabolites, Antineoplastic; Arabinonucleosides; Clofarabine; Combined Modality Therapy; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Survival Analysis | 2017 |
The activity and toxicity of low dose clofarabine against relapsed or refractory myeloma.
Topics: Adenine Nucleotides; Adult; Aged; Arabinonucleosides; Clofarabine; Female; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Neutropenia | 2006 |